Duspatalin - instructions for use, analogs, reviews and release forms (200 mg retard capsules, 135 mg tablets) for the treatment of gastrointestinal spasms in adults, children and in pregnancy

In this article, you can read the instructions for using the drug Duspatalin. Comments of visitors of the site - consumers of this medication, as well as opinions of doctors of specialists on the use of Duspatalin in their practice are presented. A big request is to actively add their feedback on the drug: the medicine helped or did not help get rid of the disease, which were observed complications and side effects, possibly not declared by the manufacturer in the annotation. Analogues of Duspatalin in the presence of existing structural analogues. Use to treat spasms of the digestive tract and discomfort in the intestines in adults, children, as well as during pregnancy and lactation.

Duspatalin - antispasmodic myotropic action.Has a direct effect on the smooth muscles of the gastrointestinal tract. Eliminates spasm without affecting normal intestinal motility.

Does not possess anticholinergic action.

Pharmacokinetics

Mebeverin (the active substance of the drug Duspatalin) is completely metabolized in the human body. The main metabolite circulating in the plasma is the demethylated carboxylic acid. Mebeverin metabolites are excreted by the kidneys.

Indications

• symptomatic treatment of pain, spasms, dysfunction and discomfort in the intestinal tract associated with irritable bowel syndrome;
• symptomatic treatment of spasms of the gastrointestinal tract, incl. caused by organic diseases.

Forms of release

Capsules of prolonged action 200 mg (retard).

Tablets coated with 135 mg.

Instructions for use and reception scheme

Assign 200 mg twice a day for 20 minutes before meals (morning and evening).

Capsules should be swallowed whole, not liquid, squeezed with water (not less than 100 ml).

Side effect

• hives;
• angioedema (including face);
• hypersensitivity reactions.

Contraindications

• age under 18 years (due to insufficient data on efficiency and safety);
• hypersensitivity to the components of the drug.

Application in pregnancy and lactation

There are no clinical data on the treatment of pregnant women. Prescribe duspatalin during pregnancy should be taken with caution if the expected benefit of therapy for the mother exceeds the potential risk to the fetus.

Information on the excretion of mebeverin with breast milk is not enough. Do not prescribe Duspatalin during lactation (breastfeeding).

Impact on the ability to drive vehicles and manage mechanisms

Duspatalin does not affect the ability to drive and other mechanisms.

Drug Interactions

Drug interaction of the drug Duspatalin is not described.

Analogues of the drug Duspatalin

Structural analogs for the active substance:

• Mebeverine hydrochloride;
• Niaspam;
• Sparex.

Similar medicines:

Other medicines: